Alexion Pharmaceuticals (ALXN): Q2 EPS of $0.29 beats by $0.03. Revenue of $185.7M (+47.6% Y/Y)....

|About: Alexion Pharmaceuticals... (ALXN)|By:, SA News Editor
Alexion Pharmaceuticals (ALXN): Q2 EPS of $0.29 beats by $0.03. Revenue of $185.7M (+47.6% Y/Y). Raises FY'11 revenue guidance to $745-755M and EPS to $1.10-1.15. (PR)